Status:

COMPLETED

The RAS, Fibrinolysis and Cardiopulmonary Bypass

Lead Sponsor:

Vanderbilt University

Conditions:

Coronary Artery Disease

Angiotensin Converting Enzyme

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

Each year over a million patients worldwide undergo cardiac surgery requiring cardiopulmonary bypass (CPB).1 CPB is associated with significant morbidity including hemodynamic instability, the transfu...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Subjects, 18 to 80 years of age, scheduled for elective cardiac surgery requiring CPB
  • For female subjects, the following conditions must be met:
  • postmenopausal for at least 1 year, or status-post surgical sterilization, or if of childbearing potential, utilizing adequate birth control and willing to undergo urine beta-hcg testing prior to drug treatment and on every study day

Exclusion

  • Left ventricle ejection fraction less than 30%
  • History of ACE inhibitor-induced angioedema
  • Hypotension (systolic blood pressure \<100 mmHg and evidence of hypoperfusion)
  • Hyperkalemia (baseline potassium \>5.0 mEq/L)
  • Inability to discontinue current ACE inhibitor or AT1 receptor antagonist.
  • Emergency surgery
  • Impaired renal function (serum creatinine \>1.6 mg/dl)
  • Pregnancy
  • Breast-feeding
  • Any underlying or acute disease requiring regular medication which could possibly pose a threat to the subject or make implementation of the protocol or interpretation of the study results difficult
  • History of alcohol or drug abuse
  • Treatment with any investigational drug in the 1 month preceding the study
  • Mental conditions rendering the subject unable to understand the nature, scope and possible consequences of the study
  • Inability to comply with the protocol, e.g. uncooperative attitude and unlikelihood of completing the study

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

111 Patients enrolled

Trial Details

Trial ID

NCT00607672

Start Date

August 1 2006

End Date

December 1 2011

Last Update

October 10 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

TN Valley Healthcare System

Nashville, Tennessee, United States, 37212

2

Vanderbilt University

Nashville, Tennessee, United States, 37232